share_log

Arcutis Biotherapeutics | 144: Notice of proposed sale of securities pursuant to Rule 144

SEC ·  Aug 3 04:28

Summary by Moomoo AI

Arcutis Biotherapeutics officer, Burnett Patrick, is set to sell 13,026 shares of the company's common stock on 08/01/2024, as per the latest filing. The shares, valued at an aggregate market value of $119,105, were acquired on the same date through a restricted stock vest from Arcutis Biotherapeutics. This transaction follows a recent history of sales by Patrick over the past three months, where a total of 72,952 shares were sold for gross proceeds of $636,634.
Arcutis Biotherapeutics officer, Burnett Patrick, is set to sell 13,026 shares of the company's common stock on 08/01/2024, as per the latest filing. The shares, valued at an aggregate market value of $119,105, were acquired on the same date through a restricted stock vest from Arcutis Biotherapeutics. This transaction follows a recent history of sales by Patrick over the past three months, where a total of 72,952 shares were sold for gross proceeds of $636,634.
Helpful
Not Helpful

This announcement is a separate document:

Doc 1

Disclaimer: This content is for informational and educational purposes only and does not constitute a recommendation or endorsement of any specific investment or investment strategy. Read more
    Heat List
    US
    SymbolLatest Price% Chg

    No Data

    Hot News
    Updated